MedTrace Logo

Viral Activation Transfusion Study (VATS)

NCT00000593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-07-12

No results posted yet for this study

Summary

The purpose of the trial was to determine if transfusion of allogeneic blood to HIV-1 infected persons led to immune activation and consequent induction of HIV-1 or /or Cytomegalovirus (CMV) replication, and whether this adversely affected clinical prognosis.

Conditions

  • Acquired Immunodeficiency Syndrome
  • Blood Transfusion
  • Cytomegalovirus Infections
  • HIV Infections

Interventions

PROCEDURE

blood transfusion

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Leslie Kalish · New England Research Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-11-30
Completion
2001-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000593 on ClinicalTrials.gov